| abstract |
The present invention provides thiazole compounds of formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, prodrug esters or solvate forms thereof. These compounds are inhibitors of platelet aggregation and can therefore be used as medicaments for treating or preventing thromboembolic disorders. <Formula I> In the above formula, W, Y, R 0 , R 2 , R 4 , R 5 , R 6 , R 7 , X 1 , X 2 , X 3 and X 4 are as defined herein, and all variable groups are defined herein It is as if. |